Game Changer in Malaria Care: Newborn Treatment Gains Approval in Africa!
Image Credit: antonytrivet/123rf.com For the first time, a malaria treatment specifically formulated for newborns has received approval from Swissmedic, Switzerland’s drug regulatory authority. The new medication, named Coartem Baby, is designed for infants weighing less than five kilograms, addressing a significant gap in malaria care for the most vulnerable population. Developed by pharmaceutical company Novartis,…